Cannon Global Investment Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1844427
DAVIE, FL
Position in BCRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$597,000
+$343,768 QoQ
Shares Held
59,700
+124.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.89%
of 13F equity value
Holder Rank
#151
of 316 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cannon Global Investment Management, LLC holds $1,290,013 across 2 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
66,700 | $693,013 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
59,700 | $597,000 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,000 | 59,700 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $253,232 | 26,600 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||